Scott Flora
Experienced Board Member & Chairman
Trusted Executive Advisor
About
Scott Flora, President of SFlora Consulting, LLC, is a seasoned MedTech executive that helps companies develop and execute their strategy. This is achieved through Board participation, investment, and consulting programs.
Scott is not a licensed broker and does not offer direct business development or valuation support and execution.
Scott has a passion for accelerating growth of companies focused on
improving patient outcomes and lowering the impact of surgery.
Improving Patient Quality of Life
Reducing Provider Stress
Increasing Operational Efficiency
Meaningful Savings for the Healthcare System
Scott’s Radar
MedTech Companies to Watch
Scott is currently involved in Board and advisory roles for an array of exciting MedTech organizations, including the following:
About
CytoVeris
CytoVeris is an early-stage company developing AI-powered cancer imaging technology that delivers real-time cancer tissue visualization, enabling more precise intraoperative decisions that can address significant clinical & financial needs of large and growing oncologic markets. The Tumor Margin Assessment and Profiling System (TumorMAPâ„¢) from CytoVeris is a real-time intraoperative cancer imaging solution that enables surgeons to visually assess tissue that is indicative of cancer, based on changes in metabolism and tissue microstructure between healthy and unhealthy tissues. To learn more about CytoVeris, visit https://cytoveris.com/
About
New View Surgical
New View Surgical is an early commercial stage company with a state-of-the-art laparoscopic visualization platform. The VisionPort™ System from New View Surgical delivers advanced visualization in a mobile platform, which adapts to any surgical environment. ​VisionPort was designed to alleviate common resource burdens for today’s hospital staff and is a great fit for advanced & robotic surgery. The single-use handpiece combines the laparoscope, camera, light source, and access port into one instrument. Thanks to its multi-port potential, the VisionPort System can also deliver more views for the most complex cases. To learn more about New View Surgical, visit https://www.newviewsurg.com/
About Palliare
Palliare is a commercial stage company with a state-of-the-art insufflation and smoke evacuation platform. The EVA15 Insufflation Platform from Palliare is the first insufflator of its kind to allow intelligent leak-tolerant constant pressure insufflation during laparoscopy and endoscopy. EVA15 was designed with clinical and financial stakeholders in mind and is a great fit for robotic surgery, thanks to its cost-effective price point, automatic leak management capabilities, on-demand smoke evacuation, and smaller OR footprint. To learn more about Palliare, visit https://www.palliare.com/
About
Origami Surgical
Origami Surgical is an early commercial stage company with a unique, patented portfolio engineered to enhance robotic-assisted surgery by allowing the surgeon to manage all aspects of suture use and needle disposal in clear view. The StitchKit® from Origami Surgical is a single use canister designed to pass multiple strands of suture with attached needles into the surgery site at once. The needles are parked into foam pads, holding them securely in place prior to being passed through a trocar to the surgical site. To learn more about Origami Surgical, visit https://origamisurgical.com/
Non-Board Advisory Roles
About
Caresyntax
Caresyntax is a revenue stage company that delivers a vendor-neutral, enterprise-scale data-driven surgery platform that is making surgery smarter by reducing unnecessary variation and allowing the care teams to focus on patient and case-specific variation. Caresyntax enables their customers to realize transformational improvements in their clinical, operational, and financial outcomes with data-driven surgery using AI, automation, and analytics. To learn more about Caresyntax, visit https://caresyntax.com/
About
Integrum
Performing continuous research and development, Integrum aims at providing safe medical devices, supporting a more active lifestyle, and improving quality of life. In order to meet individual needs, custom-made solutions are developed in close collaboration with scientists and clinicians. ​Since 1990, Integrum has helped hundreds of amputees to improve their quality of life with bone-anchored prostheses. lntegrum manufactures and designs the OPRA™ Implant System, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone and therefore avoid using a socket. ​Neuromotus™ is a new innovative technology developed by Integrum, used for therapy to reduce phantom limb pain after an amputation. To learn more about Integrum, visit https://integrum.se/
About
MiCare Path
MiCare Path is a revenue stage company that provides a platform that optimizes patient care through remote patient monitoring. ​MiCare Path provides real-time connectivity between musculoskeletal patients and their healthcare providers. Through a comprehensive set of tools, MiCare Path helps providers to more efficiently manage patients, empowers patients to maintain control of their life, and helps payers to eliminate waste caused by non-guided patients lost in the system. To learn more about MiCare Path, visit https://micarepath.com/
About
Corza Health
In partnership with leading private equity firm, GTCR, Corza Health is rewriting the model for building and scaling health and life science companies. ​Corza Health is committed to changing the healthcare system through investing in like-minded companies and driving better financial, operational, and clinical outcomes. Focusing on leading organizations with dynamic management teams, Corza Health provides governance, strategic insights, and growth capital to expand equity value. To learn more about Corza Health, visit https://corzahealth.com/
Scott's Career
Leadership Roles
- CEO
- President, Surgical Devices
- CEO
- Smith+Nephew Orthopedics
- President, Orthopedics
- Smith+Nephew Ioptex
- Global Marketing and Sales VP
Past Boards, Projects, and Due Diligence Work
